Guoqiang Dong

发表

Discovery of novel human acrosin inhibitors by virtual screening

Jue Zhang, Xuefei Liu, Guoqiang Dong, 2011, J. Comput. Aided Mol. Des..

Computational Fragment-Based Drug Design

Chen Wang, Guoqiang Dong, Chunquan Sheng, 2015 .

Homology modeling and molecular dynamics simulation of N-myristoyltransferase from protozoan parasites: active site characterization and insights into rational inhibitor design

Wei Guo, Wenya Wang, Guoqiang Dong, 2009, J. Comput. Aided Mol. Des..

Structural simplification: an efficient strategy in lead optimization

Guoqiang Dong, Chunquan Sheng, Shengzheng Wang, 2019, Acta pharmaceutica Sinica. B.

State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors.

Guoqiang Dong, Wei Wang, Wannian Zhang, 2015, Chemical Society reviews.

Chlorin p6-Based Water-Soluble Amino Acid Derivatives as Potent Photosensitizers for Photodynamic Therapy.

Buhong Li, Guoqiang Dong, Zou Tan, 2016, Journal of medicinal chemistry.

Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors.

Wei Chen, Guoqiang Dong, Zhenyuan Miao, 2015, ACS medicinal chemistry letters.

Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents.

Guoqiang Dong, Shengzheng Wang, Zhenyuan Miao, 2010, Journal of medicinal chemistry.

Discovery, synthesis, and biological evaluation of orally active pyrrolidone derivatives as novel inhibitors of p53-MDM2 protein-protein interaction.

Guoqiang Dong, Shengzheng Wang, Zhenyuan Miao, 2012, Journal of medicinal chemistry.

Synthesis and biological evaluation of thio-benzodiazepines as novel small molecule inhibitors of the p53-MDM2 protein-protein interaction.

Guoqiang Dong, Shengzheng Wang, Yang Liu, 2011, European journal of medicinal chemistry.